The Philippines is among countries seen at higher risk.

DOST Secretary Fortunato de la Peña said the biotechnology firm based in Australia has informed the department that it is willing to conduct clinical trial and manufacturing of its potential vaccines against COVID-19 in the Philippines.

In a disclosure to the stock exchange on Monday, the property unit of the SM Group reported a consolidated net income of P14.4 billion in the first 9 months, down 48% year-on-year.

"We’ve noticed our citizens are really being careful now. Despite having more transportation options resuming, they still don’t go out as much," Año said in an interview aired over ABS-CBN's TeleRadyo. 

(Updated) The clinical trial of candidate vaccines against coronavirus disease led by the World Health Organization will start in December, the Department of Health said Monday.